Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Factor VIII Deficiency Treatment market report explains the definition, types, applications, major countries, and major players of the Factor VIII Deficiency Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Octapharma
Pfizer
Shire
Novo Nordisk
Spark Therapeutics
F Hoffmann-La Roche
Swedish Orphan Biovitrum
Biogen Idec
BioMarin Pharmaceutical
Uniqure NV
Bayer HealthCare
Amarna Therapeutics
Grifols
Dimension Therapeutics
CSL
Sangamo Therapeutics
Kedrion
By Type:
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment
By End-User:
Hospitals
Clinics
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Factor VIII Deficiency Treatment Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Factor VIII Deficiency Treatment Outlook to 2028- Original Forecasts
-
2.2 Factor VIII Deficiency Treatment Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Factor VIII Deficiency Treatment Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Factor VIII Deficiency Treatment Market- Recent Developments
-
6.1 Factor VIII Deficiency Treatment Market News and Developments
-
6.2 Factor VIII Deficiency Treatment Market Deals Landscape
7 Factor VIII Deficiency Treatment Raw Materials and Cost Structure Analysis
-
7.1 Factor VIII Deficiency Treatment Key Raw Materials
-
7.2 Factor VIII Deficiency Treatment Price Trend of Key Raw Materials
-
7.3 Factor VIII Deficiency Treatment Key Suppliers of Raw Materials
-
7.4 Factor VIII Deficiency Treatment Market Concentration Rate of Raw Materials
-
7.5 Factor VIII Deficiency Treatment Cost Structure Analysis
-
7.5.1 Factor VIII Deficiency Treatment Raw Materials Analysis
-
7.5.2 Factor VIII Deficiency Treatment Labor Cost Analysis
-
7.5.3 Factor VIII Deficiency Treatment Manufacturing Expenses Analysis
8 Global Factor VIII Deficiency Treatment Import and Export Analysis (Top 10 Countries)
-
8.1 Global Factor VIII Deficiency Treatment Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Factor VIII Deficiency Treatment Export by Region (Top 10 Countries) (2017-2028)
9 Global Factor VIII Deficiency Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Factor VIII Deficiency Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hemophilia A Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hemophilia A Inhibitors Treatment Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Von Willebrand Disease Treatment Consumption and Growth Rate (2017-2022)
-
9.2 Global Factor VIII Deficiency Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Factor VIII Deficiency Treatment Market Analysis and Outlook till 2022
-
10.1 Global Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.2.2 Canada Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.2.3 Mexico Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.2 UK Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.3 Spain Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.4 Belgium Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.5 France Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.6 Italy Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.7 Denmark Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.8 Finland Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.9 Norway Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.10 Sweden Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.11 Poland Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.12 Russia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.3.13 Turkey Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.2 Japan Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.3 India Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.4 South Korea Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.5 Pakistan Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.6 Bangladesh Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.7 Indonesia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.8 Thailand Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.9 Singapore Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.10 Malaysia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.11 Philippines Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.4.12 Vietnam Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.2 Colombia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.3 Chile Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.4 Argentina Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.5 Venezuela Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.6 Peru Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.7 Puerto Rico Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.5.8 Ecuador Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6.2 Kuwait Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6.3 Oman Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6.4 Qatar Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6.5 Saudi Arabia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.6.6 United Arab Emirates Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.7.2 South Africa Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.7.3 Egypt Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.7.4 Algeria Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Factor VIII Deficiency Treatment Consumption (2017-2022)
-
10.8.2 New Zealand Factor VIII Deficiency Treatment Consumption (2017-2022)
11 Global Factor VIII Deficiency Treatment Competitive Analysis
-
11.1 Octapharma
-
11.1.1 Octapharma Company Details
-
11.1.2 Octapharma Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Octapharma Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.1.4 Octapharma Factor VIII Deficiency Treatment Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.2.4 Pfizer Factor VIII Deficiency Treatment Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Shire
-
11.3.1 Shire Company Details
-
11.3.2 Shire Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Shire Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.3.4 Shire Factor VIII Deficiency Treatment Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novo Nordisk
-
11.4.1 Novo Nordisk Company Details
-
11.4.2 Novo Nordisk Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novo Nordisk Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.4.4 Novo Nordisk Factor VIII Deficiency Treatment Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Spark Therapeutics
-
11.5.1 Spark Therapeutics Company Details
-
11.5.2 Spark Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Spark Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.5.4 Spark Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 F Hoffmann-La Roche
-
11.6.1 F Hoffmann-La Roche Company Details
-
11.6.2 F Hoffmann-La Roche Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 F Hoffmann-La Roche Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.6.4 F Hoffmann-La Roche Factor VIII Deficiency Treatment Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Swedish Orphan Biovitrum
-
11.7.1 Swedish Orphan Biovitrum Company Details
-
11.7.2 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.7.4 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Biogen Idec
-
11.8.1 Biogen Idec Company Details
-
11.8.2 Biogen Idec Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Biogen Idec Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.8.4 Biogen Idec Factor VIII Deficiency Treatment Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 BioMarin Pharmaceutical
-
11.9.1 BioMarin Pharmaceutical Company Details
-
11.9.2 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.9.4 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Uniqure NV
-
11.10.1 Uniqure NV Company Details
-
11.10.2 Uniqure NV Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Uniqure NV Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.10.4 Uniqure NV Factor VIII Deficiency Treatment Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Bayer HealthCare
-
11.11.1 Bayer HealthCare Company Details
-
11.11.2 Bayer HealthCare Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Bayer HealthCare Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.11.4 Bayer HealthCare Factor VIII Deficiency Treatment Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Amarna Therapeutics
-
11.12.1 Amarna Therapeutics Company Details
-
11.12.2 Amarna Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Amarna Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.12.4 Amarna Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Grifols
-
11.13.1 Grifols Company Details
-
11.13.2 Grifols Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Grifols Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.13.4 Grifols Factor VIII Deficiency Treatment Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Dimension Therapeutics
-
11.14.1 Dimension Therapeutics Company Details
-
11.14.2 Dimension Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Dimension Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.14.4 Dimension Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 CSL
-
11.15.1 CSL Company Details
-
11.15.2 CSL Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 CSL Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.15.4 CSL Factor VIII Deficiency Treatment Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Sangamo Therapeutics
-
11.16.1 Sangamo Therapeutics Company Details
-
11.16.2 Sangamo Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.16.4 Sangamo Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Kedrion
-
11.17.1 Kedrion Company Details
-
11.17.2 Kedrion Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Kedrion Factor VIII Deficiency Treatment Main Business and Markets Served
-
11.17.4 Kedrion Factor VIII Deficiency Treatment Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Factor VIII Deficiency Treatment Market Outlook by Types and Applications to 2028
-
12.1 Global Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Hemophilia A Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Hemophilia A Inhibitors Treatment Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Von Willebrand Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Factor VIII Deficiency Treatment Market Analysis and Outlook to 2028
-
13.1 Global Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.2.2 Canada Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.2.3 Mexico Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.2 UK Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.3 Spain Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.4 Belgium Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.5 France Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.6 Italy Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.7 Denmark Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.8 Finland Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.9 Norway Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.10 Sweden Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.11 Poland Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.12 Russia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.3.13 Turkey Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.2 Japan Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.3 India Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.4 South Korea Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.8 Thailand Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.9 Singapore Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.11 Philippines Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.2 Colombia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.3 Chile Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.4 Argentina Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.6 Peru Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6.3 Oman Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6.4 Qatar Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.7.2 South Africa Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.7.3 Egypt Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.7.4 Algeria Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Factor VIII Deficiency Treatment Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Factor VIII Deficiency Treatment
-
Figure of Factor VIII Deficiency Treatment Picture
-
Table Global Factor VIII Deficiency Treatment Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Factor VIII Deficiency Treatment Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Hemophilia A Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia A Inhibitors Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Von Willebrand Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Table North America Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure United States Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Canada Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Mexico Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure Germany Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure UK Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Spain Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Belgium Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure France Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Italy Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Denmark Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Finland Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Norway Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Sweden Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Poland Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Russia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Turkey Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table APAC Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure China Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Thailand Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Singapore Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Philippines Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table South America Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure Brazil Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Colombia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Chile Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Argentina Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Peru Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table GCC Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure Bahrain Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Oman Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Qatar Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Africa Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure Nigeria Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Africa Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Egypt Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Algeria Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Oceania Factor VIII Deficiency Treatment Consumption by Country (2017-2022)
-
Figure Australia Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Factor VIII Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Octapharma Company Details
-
Table Octapharma Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Octapharma Factor VIII Deficiency Treatment Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Pfizer Factor VIII Deficiency Treatment Product Portfolio
-
Table Shire Company Details
-
Table Shire Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Shire Factor VIII Deficiency Treatment Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Novo Nordisk Factor VIII Deficiency Treatment Product Portfolio
-
Table Spark Therapeutics Company Details
-
Table Spark Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Spark Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table F Hoffmann-La Roche Factor VIII Deficiency Treatment Product Portfolio
-
Table Swedish Orphan Biovitrum Company Details
-
Table Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product Portfolio
-
Table Biogen Idec Company Details
-
Table Biogen Idec Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Biogen Idec Factor VIII Deficiency Treatment Product Portfolio
-
Table BioMarin Pharmaceutical Company Details
-
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product Portfolio
-
Table Uniqure NV Company Details
-
Table Uniqure NV Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Uniqure NV Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Uniqure NV Factor VIII Deficiency Treatment Product Portfolio
-
Table Bayer HealthCare Company Details
-
Table Bayer HealthCare Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Bayer HealthCare Factor VIII Deficiency Treatment Product Portfolio
-
Table Amarna Therapeutics Company Details
-
Table Amarna Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amarna Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Amarna Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
Table Grifols Company Details
-
Table Grifols Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Grifols Factor VIII Deficiency Treatment Product Portfolio
-
Table Dimension Therapeutics Company Details
-
Table Dimension Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dimension Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Dimension Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
Table CSL Company Details
-
Table CSL Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table CSL Factor VIII Deficiency Treatment Product Portfolio
-
Table Sangamo Therapeutics Company Details
-
Table Sangamo Therapeutics Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Sangamo Therapeutics Factor VIII Deficiency Treatment Product Portfolio
-
Table Kedrion Company Details
-
Table Kedrion Factor VIII Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Factor VIII Deficiency Treatment Main Business and Markets Served
-
Table Kedrion Factor VIII Deficiency Treatment Product Portfolio
-
Figure Global Hemophilia A Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia A Inhibitors Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Von Willebrand Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Table North America Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure Germany Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure China Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure Brazil Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Factor VIII Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure Australia Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Factor VIII Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
